The market for genomics is expected to grow as growth in investments & funds for genomics, declining cost of sequencing procedures, increasing number of start-up companies, technological advancements in genomics are expected to fuel the market growth during the forecast period. In addition, the technologies of genomics are likely to have a positive impact on the growth of the market in the coming years.
The genomics is defined as the study of a gene and its functioning. The concept of genomics is aimed to understand the architecture of the genome which is comprised of the deoxyribo nucleic acid (DNA), ribo nucleic acid (RNA) and proteins. Genomics is meant to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The report would be of an interest to various stakeholders operating in the genomics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPTE100000730/
The objective of the study is to describe, define, and forecast the genomics market by technology, product & services, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.
The major players operating in the genomics market include Thermo Fisher Scientific Inc., Illumina Inc., and Eurofins, Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Danaher, and GE Healthcare.
For instance, in October 2018, Roche launched the three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumours, complement Roche’s NGS ctDNA kits for oncology research. The developments performed by the companies are helping the market to grow in the coming years.
Sequencing Segment is expected to grow the Market for Genomics over the Forecast Period for Technology Segment.
Global genomics market, based on technology was segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. In 2017, sequencing segment held the largest share of the market, by technology. Moreover, the sequencing segment held the largest share of the market owing to its variant libraries, genes, operons, increase the function of proteins, and to test the particular gene. However, the microarray segment is expected to grow at the fastest rate during the coming years.
Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPTE100000730/
The report segments the global genomics market as follows:
Global Genomics Market – By Technology
• Sequencing
• Microarray
• Polymerase Chain Reaction
• Nucleic Acid Extraction and Purification
• Others
Global Genomics Market – By Product & Services
• Instruments/Systems
• Consumables
• Services
Global Genomics Market – By Application
• Diagnostics
• Drug Discovery and Development
• Precision/Personalized Medicine
• Agriculture & Animal Research
Global Genomics Market – By End User
• Research Centers
• Hospitals & Clinics
• Biotechnology & Pharmaceutical Companies
Media ContactCompany Name: The Insight PartnersContact Person: Sam JEmail: Send EmailPhone: +1-646-491-9876Address:Hadapsar City: PuneState: MaharashtraCountry: IndiaWebsite: https://www.theinsightpartners.com/reports/vaccines-market
